Multiglandular Hormone Deficiency in a Patient with Systemic Capillary Leak Syndrome

por Then, Cornelia, Ritzel, Katrin, Seibold, Christa, Mann, Johannes F. E., Reincke, Martin
Publicado no Case Rep Med (2015)

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo contro...

por Marre, Michel, Lievre, Michel, Chatellier, Gilles, Mann, Johannes F E, Passa, Philippe, Ménard, Joël
Publicado em 2004

Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist

por Hoekman, Jamo, Lambers Heerspink, Hiddo J., Viberti, Giancarlo, Green, Damien, Mann, Johannes F.E., de Zeeuw, Dick
Publicado em 2014

Avosentan for Overt Diabetic Nephropathy

por Mann, Johannes F.E., Green, Damian, Jamerson, Kenneth, Ruilope, Luis M., Kuranoff, Susan J., Littke, Thomas, Viberti, Giancarlo
Publicado em 2010

Blood HER2 and Uromodulin as Causal Mediators of CKD

por Sjaarda, Jennifer, Gerstein, Hertzel C., Yusuf, Salim, Treleaven, Darin, Walsh, Michael, Mann, Johannes F.E., Hess, Sibylle, Paré, Guillaume
Publicado no J Am Soc Nephrol (2018)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL

por Schuh, Elisabeth, Ertl-Wagner, Birgit, Lohse, Peter, Wolf, Waltraud, Mann, Johannes F., Lee-Kirsch, Min Ae, Hohlfeld, Reinhard, Kümpfel, Tania
Publicado no Neurol Neuroimmunol Neuroinflamm (2014)

Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures

por Barzilay, Joshua I., Gao, Peggy, Clase, Catherine M., Mente, Andrew, Mann, Johannes F.E., Sleight, Peter, Yusuf, Salim, Teo, Koon K.
Publicado em 2013

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial

por Mann, Johannes F. E., Fonseca, Vivian, Mosenzon, Ofri, Raz, Itamar, Goldman, Bryan, Idorn, Thomas, von Scholten, Bernt Johan, Poulter, Neil R.
Publicado no Circulation (2018)

A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND

por Shiffman, Dov, Pare, Guillaume, Oberbauer, Rainer, Louie, Judy Z., Rowland, Charles M., Devlin, James J., Mann, Johannes F., McQueen, Matthew J.
Publicado em 2014

Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial

por Nauck, Michael A., Buse, John B., Mann, Johannes F. E., Pocock, Stuart, Bosch‐Traberg, Heidrun, Frimer‐Larsen, Helle, Ye, Qing, Gray, Alastair
Publicado no Diabetes Obes Metab (2018)

Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease

por Mann, Johannes F.E., Fonseca, Vivian A., Poulter, Neil R., Raz, Itamar, Idorn, Thomas, Rasmussen, Søren, von Scholten, Bernt Johan, Mosenzon, Ofri
Publicado no Clin J Am Soc Nephrol (2020)

Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease

por Schmieder, Roland E., Mann, Johannes F. E., Schumacher, Helmut, Gao, Peggy, Mancia, Giuseppe, Weber, Michael A., McQueen, Matthew, Koon, Teo, Yusuf, Salim
Publicado em 2011

Risk Prediction for Early CKD in Type 2 Diabetes

por Dunkler, Daniela, Gao, Peggy, Lee, Shun Fu, Heinze, Georg, Clase, Catherine M., Tobe, Sheldon, Teo, Koon K., Gerstein, Hertzel, Mann, Johannes F.E., Oberbauer, Rainer
Publicado no Clin J Am Soc Nephrol (2015)

Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITO...

por Gesualdo, Loreto, Combe, Christian, Covic, Adrian, Dellanna, Frank, Goldsmith, David, London, Gérard, Mann, Johannes F., Zaoui, Philippe, Turner, Matthew, Muenzberg, Mike, MacDonald, Karen, Abraham, Ivo
Publicado no Int Urol Nephrol (2015)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

por Floege, Jürgen, Covic, Adrian C., Ketteler, Markus, Mann, Johannes F.E., Rastogi, Anjay, Spinowitz, Bruce, Chong, Edward M.F., Gaillard, Sylvain, Lisk, Laura J., Sprague, Stuart M.
Publicado no Nephrol Dial Transplant (2015)

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

por Persson, Frederik, Bain, Stephen C., Mosenzon, Ofri, Heerspink, Hiddo J.L., Mann, Johannes F.E., Pratley, Richard, Raz, Itamar, Idorn, Thomas, Rasmussen, Søren, von Scholten, Bernt Johan, Rossing, Peter
Publicado no Diabetes Care (2021)

Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach

por Clase, Catherine M., Fu, Edouard L., Joseph, Meera, Beale, Rupert C.L., Dolovich, Myrna B., Jardine, Meg, Mann, Johannes F.E., Pecoits-Filho, Roberto, Winkelmayer, Wolfgang C., Carrero, Juan J.
Publicado no Ann Intern Med (2020)

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial

por Mosenzon, Ofri, Bain, Stephen C., Heerspink, Hiddo J. L., Idorn, Thomas, Mann, Johannes F. E., Persson, Frederik, Pratley, Richard E., Rasmussen, Søren, Rossing, Peter, von Scholten, Bernt Johan, Raz, Itamar
Publicado no Diabetes Obes Metab (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

por Buse, John B., Bain, Stephen C., Mann, Johannes F.E., Nauck, Michael A., Nissen, Steven E., Pocock, Stuart, Poulter, Neil R., Pratley, Richard E., Linder, Martin, Monk Fries, Tea, Ørsted, David D., Zinman, Bernard
Publicado no Diabetes Care (2020)

LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

por Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
Publicado em 2014